Articles by Keyword for

Drugs developed to treat Alzheimer's disease produce only fleeting memory improvements and do not slow the overall course of the disease. Acetylcholinesterase inhibitors such as Aricept, Razadyne, and Exelon and NMDA receptor inhibitors such as Namenda have very limited value. There is a new experimental drug called J147 that at least in mice enhances...